Keisuke OKUHARA, CEO, and Takashi YAMAMOTO, CTO, received a "Special Award" in the Challenging Spirit category at the EY Entrepreneur of...

Cancer Genome Data Analysis" (MEDSi), edited by Science and Technology Advisor Hidemasa BONO (Project Professor, Graduate School of...

Science and Technology Advisor Hidemasa BONO (Graduate School of Integrated Biosciences, Hiroshima University, Specially Appointed...

Science and Technology Advisor Hidemasa BONO (Project Professor, Graduate School of Integrated Biosciences, Hiroshima University), in...

R&D project submitted by Pt Bio Inc. has been selected for the "FY2022 Bioeconomy Industry Creation Support Project Subsidy" by Hiroshima...

The Nihon Keizai Shimbun published an interview with Takashi YAMAMOTO, CTO (Professor, Hiroshima University). In the article, Dr....

The "Bio-Digital Transformation (Bio-DX) Industry-Academia Co-Creation Center" represented by Hiroshima University has been promoted to a...

Keisuke OKUHARA, CEO of PtBio Inc., received the "JVCA Special Encouragement Award" at the 21st Japan Venture Awards (abbreviated as JVA)...

PtBio Inc. (Head office: Higashihiroshima City, Hiroshima Prefecture, CEO: Keisuke OKUHARA, hereinafter "PtB") has raised a total of 280...

The December 2021 issue of Experimental Medicine, "Bio DX for everyone - Let's Start Treasure Hunting in the Sea of Public Data," planned...